Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Bredeson

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
British Journal of Haematology|November 1, 1995
2-Chloro-deoxyadenosine therapy for giant lymph node hyperplasiaL Bordeleau, C Bredeson, S Markman
The CLAO Journal : Official Publication of the Contact Lens Association of Ophthalmologists, Inc|July 1, 1994
A prospective evaluation of Unilens soft multifocal contact lenses in 100 patientsM B Shapiro, D C Bredeson
Journal of Clinical Apheresis|August 10, 1999
Selection of appropriate venous access for the collection of peripheral blood progenitor cells by experienced apheresis nursesS McDiarmid, C Bredeson, L B Huebsch
Bone Marrow Transplantation|March 12, 2014
A plerixafor-based strategy allows adequate hematopoietic stem cell collection in poor mobilizers: results from the Canadian Special Access ProgramD Sheppard, C Bredeson, L Huebsch, et al.
Transfusion Medicine (Oxford, England)|April 6, 2016
Eltrombopag after allogeneic haematopoietic cell transplantation in a case of poor graft function and systematic review of the literatureJ Dyba, A Tinmouth, C Bredeson, et al.
Current Oncology (Toronto, Ont.)|August 19, 2016
Plerixafor for autologous stem-cell mobilization and transplantation for patients in OntarioC T Kouroukis, N P Varela, C Bredeson, et al.
Bone Marrow Transplantation|December 24, 1997
Cost analysis of the introduction of PBPC for autologous transplantation: effect of switching from bone marrow (BM) to peripheral blood progenitor cells (PBPC)C Bredeson, J Malcolm, M Davis, et al.
Current Oncology (Toronto, Ont.)|April 26, 2014
Extracorporeal photopheresis in the management of graft-versus-host diseaseC Bredeson, R B Rumble, N P Varela, et al.
Bone Marrow Transplantation|July 15, 2003
Tumor load in patients with follicular lymphoma post stem cell transplantation may correlate with clinical courseC-C Chang, C Bredeson, M Juckett, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 18, 2000
Autologous blood and marrow transplantation in patients 60 years and olderC S Leger, C Bredeson, B Kearns, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
British Journal of Haematology|November 1, 1995
2-Chloro-deoxyadenosine therapy for giant lymph node hyperplasiaL Bordeleau, C Bredeson, S Markman
The CLAO Journal : Official Publication of the Contact Lens Association of Ophthalmologists, Inc|July 1, 1994
A prospective evaluation of Unilens soft multifocal contact lenses in 100 patientsM B Shapiro, D C Bredeson
Journal of Clinical Apheresis|August 10, 1999
Selection of appropriate venous access for the collection of peripheral blood progenitor cells by experienced apheresis nursesS McDiarmid, C Bredeson, L B Huebsch
Bone Marrow Transplantation|March 12, 2014
A plerixafor-based strategy allows adequate hematopoietic stem cell collection in poor mobilizers: results from the Canadian Special Access ProgramD Sheppard, C Bredeson, L Huebsch, et al.
Transfusion Medicine (Oxford, England)|April 6, 2016
Eltrombopag after allogeneic haematopoietic cell transplantation in a case of poor graft function and systematic review of the literatureJ Dyba, A Tinmouth, C Bredeson, et al.
Current Oncology (Toronto, Ont.)|August 19, 2016
Plerixafor for autologous stem-cell mobilization and transplantation for patients in OntarioC T Kouroukis, N P Varela, C Bredeson, et al.
Bone Marrow Transplantation|December 24, 1997
Cost analysis of the introduction of PBPC for autologous transplantation: effect of switching from bone marrow (BM) to peripheral blood progenitor cells (PBPC)C Bredeson, J Malcolm, M Davis, et al.
Current Oncology (Toronto, Ont.)|April 26, 2014
Extracorporeal photopheresis in the management of graft-versus-host diseaseC Bredeson, R B Rumble, N P Varela, et al.
Bone Marrow Transplantation|July 15, 2003
Tumor load in patients with follicular lymphoma post stem cell transplantation may correlate with clinical courseC-C Chang, C Bredeson, M Juckett, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 18, 2000
Autologous blood and marrow transplantation in patients 60 years and olderC S Leger, C Bredeson, B Kearns, et al.
Pageof 4